Results 251 to 260 of about 522,058 (284)
Some of the next articles are maybe not open access.
Towards widening access to medicine
Medical Teacher, 2012Dear SirDiversity at medical school would lead to a more culturally sensitive education process, vital in producing competent doctors capable of serving the UK's increasingly heterogeneous populati...
Alhafidz, Hamdan, Edward, Lea
openaire +2 more sources
The new Access to Medicine Index
The Lancet, 2008Tim Reed of Health Action International (Sept 13, p 890) seems less than fully content with the Access to Medicine Index published in June, 2008, because it “has turned out as an attractive new business tool for big pharma.” His disapproval is a bit premature and might be partly based on inaccurate information.
Mohammed K, Ali, K M Venkat, Narayan
+7 more sources
Empower: Access to Medicine – Working Towards Early Access
Reviews on Recent Clinical Trials, 2015Empower: Access to Medicine's contribution will document the founding of Empower: Access to Medicine and tactics used to create a lobbying campaign designed to facilitate the debate around barriers to medical innovation and patient access to medicines.
Jennifer Bryant, Pearson +2 more
openaire +2 more sources
Patent Funded Access to Medicines
Developing World Bioethics, 2014AbstractInstead of impeding access to essential medicines in developing countries, the essay explores why and how patents can serve as a source of funding for the much needed access to medicine. Instead of a weakening of patents, prolonged protection periods are suggested in circumstances where there is widespread lack of access.
openaire +2 more sources
Access to Databases in Complementary Medicine
The Journal of Alternative and Complementary Medicine, 2000Access to medical databases is a keystone for obtaining up-to-date and complete information for physicians. In the last few years, the rapid growth of the World Wide Web has given rise to an information revolution, enabling health care providers to gain access (often free) to an expanding volume of information that was previously inaccessible.
Allais G +4 more
openaire +2 more sources
Pathways to faster access to medicines
Drug and Therapeutics Bulletin, 2018Before a medicine can be marketed in the UK, marketing authorisation approval is needed from the European Medicines Agency (EMA) or the Medicines and Healthcare products Regulatory Agency (MHRA). However, the time it takes to appraise a medicine is considered by some to delay access to new treatments for people with serious or life-threatening ...
openaire +2 more sources